COMMON SHARE PURCHASE WARRANT CLEARMIND MEDICINE INC.Common Share Purchase • March 27th, 2023 • Clearmind Medicine Inc. • Pharmaceutical preparations • New York
THIS COMMON SHARE PURCHASE WARRANT (the “Warrant”) certifies that, for value received, [●] or its assigns (the “Holder,” provided that a “Holder” shall include, if the Warrants are held in “street name,” a Participant, any designee appointed by such Participant and each “beneficial owner” of such Warrants) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on [●], 2028 (the “Termination Date”) but not thereafter, to subscribe for and purchase from Clearmind Medicine Inc., an British Columbia company (the “Company”), up to [●] Common Shares (as subject to adjustment hereunder, the “Warrant Shares”). The purchase price of one Common Share under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b). This Warrant shall initially be issued and maintained in the form of a security held in
e) "Control" means the possession, directly or indirectly, of the power to direct or cause the direction of the management and policies of a Person, whether through the ownership of voting stock or interests, by contract or otherwise. 1Common Share Purchase • May 16th, 2005 • Provectus Pharmaceuticals Inc • Pharmaceutical preparations • Nevada
COMMON SHARE PURCHASE WARRANT CLEARMIND MEDICINE INC.Common Share Purchase • July 17th, 2023 • Clearmind Medicine Inc. • Pharmaceutical preparations • New York
THIS COMMON SHARE PURCHASE WARRANT (the “Warrant”) certifies that, for value received, [●] or its assigns (the “Holder,” provided that a “Holder” shall include, if the Warrants are held in “street name,” a Participant, any designee appointed by such Participant and each “beneficial owner” of such Warrants) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on [●], 2028 (the “Termination Date”) but not thereafter, to subscribe for and purchase from Clearmind Medicine Inc., an British Columbia company (the “Company”), up to [●] Common Shares (as subject to adjustment hereunder, the “Warrant Shares”). The purchase price of one Common Share under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b). This Warrant shall initially be issued and maintained in the form of a security held in
COMMON SHARE WARRANT To Subscribe for Common Shares of Metron Technology N.V.Common Share Purchase • August 12th, 2004 • Metron Technology N V • Special industry machinery, nec
THIS COMMON SHARE PURCHASE WARRANT CERTIFIES that, for value received, (the “Holder”), is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after June , 2004 (the “Initial Exercise Date”) and on or prior to the earlier of (i) the close of business on the fifth anniversary of the Initial Exercise Date or (ii) 30 days after the notice of a mandatory termination of this Warrant pursuant to Section 17 (the “Termination Date”) but not thereafter, to subscribe for, up to common shares (the “Common Stock”), par value (based on application of Section 2:67c of the Netherlands Civil Code) EUR0.44 per share in the capital of Metron Technology N.V., a corporation incorporated under the laws of The Netherlands (the “Company”) (such Common Stock hereinafter referred to as the “Warrant Shares”). The subscription price of one Warrant Share (the “Exercise Price”) under this Warrant shall be $ , subject to adjustment hereunder
COMMON SHARE PURCHASE WARRANT To Purchase 250,000 Common Shares of Developers Diversified Realty CorporationCommon Share Purchase • September 18th, 2009 • Developers Diversified Realty Corp • Real estate investment trusts
THIS COMMON SHARE PURCHASE WARRANT CERTIFIES that, for value received, Dr. Michael Otto or his permitted transferees, assigns and successors (the “Holder"), is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after September 18, 2009 (the “Issue Date") and on or prior to the close of business on the 5th anniversary of the Issue Date (the “Termination Date") but not thereafter, to subscribe for and purchase from Developers Diversified Realty Corporation, an Ohio corporation (the “Company"), up to 250,000 common shares (the “Warrant Shares"), par value $0.10 per share, of the Company (the “Common Stock"). The purchase price of one share of Common Stock (the “Exercise Price") under this Warrant shall be $6.00, subject to adjustment herein. The Exercise Price and the number of Warrant Shares for which the Warrant is exercisable shall be subject to adjustment as provided herein.
COMMON SHARE PURCHASE WARRANT PISHPOSH, INC.Common Share Purchase • October 21st, 2022 • PishPosh, Inc. • Retail-nonstore retailers
THIS COMMON SHARE PURCHASE WARRANT (the “Warrant”) certifies that, for value received, [_________________], or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date that the Company’s Common Shares have been approved for and are listed for trading on a Trading Market (the “Initial Exercise Date”) until the close of business on the five (5) year anniversary of the Initial Exercise Date (the “Termination Date”) but not thereafter, to subscribe for and purchase from PISHPOSH, INC., a Delaware corporation (the “Company”), up to [________] shares of Common Stock (as subject to adjustment hereunder, the “Warrant Shares”). The purchase price of one Warrant Share under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
COMMON SHARE PURCHASE WARRANT ÆTERNA ZENTARIS INC.Common Share Purchase • October 20th, 2009 • Aeterna Zentaris Inc. • Pharmaceutical preparations
THIS COMMON SHARE PURCHASE WARRANT (the “Warrant”) certifies that, for value received, ___(the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after October ___, 2009 (the “Initial Exercise Date”) and on or prior to the close of business on October ___, 2014 (the “Termination Date”) but not thereafter, to subscribe for and purchase from Æterna Zentaris Inc., a Canadian corporation (the “Corporation”), up to ___common shares (the “Warrant Shares”) of the capital of the Corporation (the “Common Shares”). The purchase price of one Common Share under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b) hereof.
COMMON SHARE PURCHASE WARRANTCommon Share Purchase • September 10th, 2021 • Globe Net Wireless Corp. • Services-computer programming, data processing, etc. • New York
THIS COMMON SHARE PURCHASE WARRANT (the “Warrant”) certifies that, for value received, MCUS LLC or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on the three year anniversary hereof_(the “Termination Date”) but not thereafter, to subscribe for and purchase from Stemtech Corporation (“Stemtech”), up to 500,0000 Common Shares (as subject to adjustment hereunder, the “Warrant Shares”), exercisable at a strike price or exercise price of $3.00 and expiring in 3 years from August 30, 2021.
COMMON SHARE PURCHASE WARRANT BriaCell Therapeutics Corp.Common Share Purchase • May 17th, 2024 • BriaCell Therapeutics Corp. • Pharmaceutical preparations
THIS COMMON SHARE PURCHASE WARRANT (the “Warrant”) certifies that, for value received, __________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after November 17, 2024 (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on November 17, 2029 (the “Termination Date”) but not thereafter, to subscribe for and purchase from BriaCell Therapeutics Corp., a British Columbia corporation (the “Company”), up to ______ shares (as subject to adjustment hereunder, the “Warrant Shares”) of the Company’s Common Shares. The purchase price of one Common Share under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
